Signaling pathways
-
BA8749 GSK-F1Summary: GSK-F1 is an orally active inhibitor. -
BA8750 VulolisibSummary: Vulolisib is a potent and orally active inhibitor.
-
BA8751 SRX3207Summary: SRX3207 is an orally active, first-of-its-kind dual inhibitor.
-
BA8752 PI4K-IN-1Summary: PI4K-IN-1 is a potent inhibitor.
-
BA8753 IPI-3063Summary: IPI-3063 is a potent and selective inhibitor.
-
BA8754 HL-8Summary: HL-8 is a molecule that targets kinases.
-
BA8755 PI3Kα-IN-4Summary: PI3Kα-IN-4 is a potent, selective and orally active inhibitor.
-
BA8756 NVS-PI3-4Summary: NVS-PI3-4 is a specific inhibitor.
-
BA8757 PI3K-IN-36Summary: PI3K-IN-36 is a potent inhibitor.
-
BA8758 ETP-46321Summary: An inhibitor.